Wells Fargo’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.36M | Sell |
56,653
-10,238
| -15% | -$968K | ﹤0.01% | 2181 |
|
|
2025
Q1 | $4.25M | Sell |
66,891
-235
| -0.4% | -$14.9K | ﹤0.01% | 2260 |
|
|
2024
Q4 | $3.12M | Buy |
67,126
+14,362
| +27% | +$667K | ﹤0.01% | 2487 |
|
|
2024
Q3 | $1.52M | Sell |
52,764
-28,058
| -35% | -$807K | ﹤0.01% | 2946 |
|
|
2024
Q2 | $1.17M | Buy |
80,822
+20,631
| +34% | +$298K | ﹤0.01% | 3084 |
|
|
2024
Q1 | $968K | Buy |
60,191
+42,633
| +243% | +$686K | ﹤0.01% | 3164 |
|
|
2023
Q4 | $349K | Buy |
17,558
+3,338
| +23% | +$66.4K | ﹤0.01% | 3747 |
|
|
2023
Q3 | $232K | Buy |
14,220
+1,600
| +13% | +$26.1K | ﹤0.01% | 3962 |
|
|
2023
Q2 | $267K | Buy |
12,620
+12,400
| +5,636% | +$262K | ﹤0.01% | 4169 |
|
|
2023
Q1 | $4.42K | Buy |
220
+20
| +10% | +$402 | ﹤0.01% | 5762 |
|
|
2022
Q4 | $5.23K | Buy |
200
+100
| +100% | +$2.61K | ﹤0.01% | 5436 |
|
|
2022
Q3 | $1K | Buy |
+100
| New | +$1K | ﹤0.01% | 6146 |
|